|
 |
|
|
| |
|
|
|
|
| Table 1. Estimated numbers of cases of HIV/AIDS, by year of diagnosis and selected characteristics of persons, 2000–2003—33 areas with confidential name-based HIV infection reporting |
|
|
|
|
View PDF
|
|
|
|
 |
|
|
|
|
| |
Year of Diagnosis |
| |
2000 |
2001 |
2002 |
2003 |
| Age at diagnosis (yrs) |
| < 13 |
196 |
238 |
210 |
161 |
| 13—14 |
36 |
43 |
36 |
50 |
| 15—24 |
3,502 |
3,568 |
3,601 |
3,847 |
| 25—34 |
9,340 |
8,920 |
9,001 |
8,722 |
| 35—44 |
11,312 |
11,072 |
11,382 |
11,299 |
| 45—54 |
4,924 |
5,179 |
5,504 |
5,821 |
| 55—64 |
1,412 |
1,496 |
1,614 |
1,681 |
| >65 |
439 |
485 |
457 |
466 |
| Race/ethnicity |
|
| White, not Hispanic |
9,962 |
9,803 |
10,214 |
10,322 |
| Black, not Hispanic |
16,257 |
16,042 |
16,216 |
16,165 |
| Hispanic |
4,340 |
4,560 |
4,833 |
4,963 |
| Asian/Pacific Islander |
177 |
162 |
187 |
273 |
| American Indian/Alaska Native |
178 |
164 |
185 |
188 |
| Transmission category |
| Male-to-male sexual contact |
13,112 |
13,483 |
14,355 |
14,532 |
| Injection drug use |
3,539 |
3,298 |
3,227 |
3,189 |
| Male-to-male sexual contact
and injection drug use |
1,364 |
1,302 |
1,256 |
1,224 |
| Heterosexual contact |
3,876 |
3,879 |
3,949 |
4,041 |
| Othera |
172 |
172 |
175 |
168 |
| Subtotal |
22,064 |
22,134 |
22,963 |
23,153 |
| Female
adult or adolescent |
|
| Injection drug use |
1,884 |
1,722 |
1,621 |
1,628 |
| Heterosexual contact |
6,854 |
6,770 |
6,870 |
6,942 |
| Othera |
160 |
138 |
142 |
163 |
| Subtotal |
8,899 |
8,630 |
8,633 |
8,733 |
| Child(<13
yrs at diagnosis) |
|
| Perinatal |
175 |
218 |
193 |
147 |
| Otherb |
22 |
20 |
17 |
15 |
| Subtotal |
197 |
238 |
210 |
162 |
| Subtotal for 32 states
with confidential name-based HIV infection reporting |
31,104 |
30,953 |
31,749 |
31,994 |
| Subtotal for U.S. dependencies,
possessions, and associated nations with confidential name-based HIV infection reporting |
57 |
49 |
57 |
54 |
| Totalc |
31,161 |
31,002 |
31,805 |
32,048 |
|
|
|
| Note. These
numbers do not represent reported case counts. Rather, these
numbers are point estimates, which result from adjustments of
reported case counts. The reported case counts are adjusted for
reporting delays and for redistribution of cases in persons initially
reported without an identified risk factor. The estimates do
not include adjustment for incomplete reporting. |
| Data include persons with a diagnosis of HIV infection. This includes persons with a diagnosis of HIV infection only, a diagnosis of HIV infection and a later AIDS diagnosis, and concurrent diagnoses of HIV infection and AIDS. |
| Since 1999, the following 33 areas have had laws or regulations requiring confidential name-based HIV infection reporting: Alabama, Alaska, Arizona, Arkansas, Colorado, Florida, Idaho, Indiana, Iowa, Kansas, Louisiana, Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Jersey, New Mexico, North Carolina, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, West Virginia, Wisconsin, Wyoming, and the U.S. Virgin Islands. Since July 1997, Florida has had confidential name-based HIV infection reporting only for new diagnoses. |
|
|
|
| a |
Includes hemophilia, blood transfusion, perinatal, and risk factor not reported or not identified. |
| b |
Includes hemophilia, blood transfusion, and risk factor not reported or not identified. |
| c |
Includes persons of unknown race or multiple races and persons of unknown sex. Because column totals were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total. |
|
|
 |
|
|
|
|
|
